论文部分内容阅读
11.直接左心辅助和双心辅助装置的研制及实验与临床应用研究 新型装置为小型、可植入式,可随患者走动。动物实验可生存0.5～1个月,完成临床试验。用3年时间完成泵体研制,动物可存活1～2周,可代替IABP,并初步用于临床。“九五”期末全套装置系统化,用于临床。 12.提高婴幼儿重症先天性心脏病外科治疗疗效的临床与实验研究 提高合并肺动脉高压或肺血管发育不良的重症先天性心脏病患儿手术适应证准确率,筛选可用于临床的肺保护措施,选择和改进手术及处理方法,取得最佳血流动力学效应。用3年时间初步确定良好的
11. Direct left ventricular assist and dual cardiac assist device development and experimental and clinical application research The new device is small, implantable, with the patient walking. Animal experiments can survive 0.5 to 1 month to complete clinical trials. With 3 years to complete the development of the pump, the animals can survive for 1 to 2 weeks, can replace IABP, and initially for clinical use. At the end of the Ninth Five-Year Plan period, the complete set of equipment was systematized for clinical use. 12. To improve the efficacy of surgical treatment of severe congenital heart disease in infants and young children clinical and experimental studies to improve pulmonary hypertension or pulmonary vascular dysplasia in children with severe congenital heart disease surgical indication accuracy, screening for clinical lung protection measures, Select and improve the operation and treatment methods, to achieve the best hemodynamic effects. With 3 years to determine the initial good